Cannabics Bolsters Team to Develop Cannabinoid Treatments for Cancer
New team members will support Cannabics' data-discovery process with the goal of identifying new cannabinoid diagnostic tests and treatments for cancer.
EVIO Labs Expands to L.A. to Meet Cannabis Analysis Demand
Due to California's July 1st testing deadline mandating licensed retailers to sell only lab tested product, the industry is expecting a significant uptick in the need for testing services.
North Dakota Selects Lab for Testing Medical Marijuana
State Medical Marijuana Director Jason Wahl says the lab will ensure medical cannabis dispensed in North Dakota is safe.
Trends in Medical Cannabis: Epidiolex and the FDA
What does the recent FDA approval recommendation for Epidiolex mean for cannabis medicine? And, what's best, synthetic or natural cannabinoids? You can get answers in this Interview.
Testing the Moisture Content of Cannabis
A cannabis testing committee has now approved to standard testing methods to help analysts accurately measure the water content of cannabis.
Cannabis: It Matters How Young You Start
Canadian researchers find that boys who start smoking pot before 15 are much more likely to have a drug problem at 28 than those who start at 15 or after.
Faster Test for Cannabis Quality, Potency Developed
Traditional tests can take upwards of 20 minutes to perform, this new one can be done in under seven.
Optimizing the Effectiveness of Cannabinoid Treatments for Epilepsy
Novel cannabinoids could provide new therapy options for patients with drug-resistant epilepsy.
CBD Significantly Reduces Seizures in Patients with Severe Form of Epilepsy
Large-scale clinical trial finds cannabidiol can dramatically reduce the number of dangerous seizures in patients with a severe form of epilepsy called Lennox–Gastaut syndrome.
